Holding the roles of Director and Senior Principal Scientific Advisor at Charles River, Sarah has extensive experience (25+ years) in both biotech and blue chip international pharmaceutical companies. Sarah has delivered multiple toxicology and safety pharmacology programs, and regulatory dossiers globally from Discovery to License, for small and large molecules, gene therapy, vaccines/adjuvants, with various regulatory interactions, including authoring regulatory guidelines: safety assessment of process residues/contaminants in vaccines (EVM re: TTC, 2012) and WHO vaccine/adjuvant guidelines (2013, 2021).
Sarah Gould, PhD
Director, Senior Principal Scientific Advisor